Árpád Illés

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers

Survivors of childhood and adolescent cancer: life-long risks and responsibilities

TFOS DEWS II pathophysiology report

The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4⁺CD25^highFoxP3⁺regulatory T cells during repeated plasmapheresis treatments of patients

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Systemic Lupus Erythematosus

Radiotherapy-induced thyroid disorders

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival

JAK2 inhibitors for myeloproliferative neoplasms: what is next?

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma

Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination

Precision glycocalyx editing as a strategy for cancer immunotherapy

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

Pheno- and Genotypic Features of Epstein-Barr Virus Associated B-Cell Lymphoproliferations in Peripheral T-Cell Lymphomas

Immunoregulatory T Cells in the Peripheral Blood of Patients with Hodgkin’s Lymphoma

Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma

Fc-Gamma-Receptor IIIa Polymorphism and Gene Expression Profile Do Not Predict the Prognosis in Diffuse Large B-cell Lymphoma Treated with R-CHOP Protocol

Hypothyroidism and Thyroiditis after Therapy for Hodgkin’s Disease

Aspects of B‐Cell Non‐Hodgkin’s Lymphoma Development: A Transition from Immune‐Reactivity to Malignancy

Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results.

Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.

Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients